Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation

International Journal of Cancer

Volumn 134, Issue 7, 2014, Pages 1659-1668

  Damiola, Francesca ^a   Byrnes, Graham ^a   Moissonnier, Monika ^a   Pertesi, Maroulio ^a   Deltour, Isabelle ^a   Fillon, Aurélie ^a   Le Calvez Kelm, Florence ^a   Tenet, Vanessa ^a   McKay Chopin, Sandrine ^a   McKay, James D ^a   Malakhova, Irina ^b   Masyakin, Vladimir ^c   Cardis, Elisabeth ^d   Lesueur, Fabienne ^a,e   Kesminiene, Ausrele ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Republican Scientific and Practical Center for Medical Technologies   (Belarus)

^c Republican Research Center for Radiation Medicine and Human Ecology   (Belarus)

^d HOSPITAL DEL MAR   (Spain)

^e INSERM U900   (France)

Author keywords

ATM; FOXE1; genetic susceptibility; papillary thyroid carcinoma; radiation induced cancer

Indexed keywords

ATM PROTEIN;

ADOLESCENT; ARTICLE; ATM GENE; BELARUS; CANCER RISK; CHERNOBYL ACCIDENT; CHILD; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; FOXE1 GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; IONIZING RADIATION; MAJOR CLINICAL STUDY; MALE; MORPHOGENESIS; NUCLEAR POWER PLANT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RADIATION DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CARCINOMA; TUMOR GENE;

ATM; FOXE1; GENETIC SUSCEPTIBILITY; PAPILLARY THYROID CARCINOMA; RADIATION-INDUCED CANCER;

ADOLESCENT; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CARCINOMA; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; CHERNOBYL NUCLEAR ACCIDENT; CHILD; CHILD, PRESCHOOL; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS, RADIATION-INDUCED; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION, IONIZING; RISK FACTORS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84892579717     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28483     Document Type: Article

References (50)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Khan A, Smellie J, Nutting C, et al. Familial nonmedullary thyroid cancer: a review of the genetics. Thyroid 2010; 20: 795-801.
3. Goldgar DE, Easton DF, Cannon-Albright LA, et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-8.
4. Kilfoy BA, Devesa SS, Ward MH, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009; 18: 1092-100.
5. Zhu C, Zheng T, Kilfoy BA, et al. A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 2009; 19: 1061-6.
6. Cardis E, Hatch M,. The Chernobyl accident-an epidemiological perspective. Clin Oncol (R Coll Radiol) 2011; 23: 251-60.
7. Schonfeld SJ, Lee C, Berrington de Gonzalez A,. Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol) 2011; 23: 244-50.
8. Stsjazhko VA, Tsyb AF, Tronko ND, et al. Childhood thyroid cancer since accident at Chernobyl. BMJ 1995; 310: 801.
9. United Nations. Sources and effects of ionizing radiation. In: Report to the General Assembly, vol. II, scientific Annexes C, D and E, UNSCEAR 2008 report. Vienna, Austria: United Nations, 2011.
10. Kabacik S, Mackay A, Tamber N, et al. Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol 2011; 87: 115-29.
11. Bonora E, Tallini G, Romeo G,. Genetic predisposition to familial nonmedullary thyroid cancer: an update of molecular findings and state-of-the-art studies. J Oncol 2010; 2010: 385206.
12. Landa I, Robledo M,. Association studies in thyroid cancer susceptibility: are we on the right track? J Mol Endocrinol 2011; 47: R43-R58.
13. Akulevich NM, Saenko VA, Rogounovitch TI, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer 2009; 16: 491-503.
14. Takahashi M, Saenko VA, Rogounovitch TI, et al. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 2010; 19: 2516-23.
15. Akdi A, Gimenez EM, Garcia-Quispes W, et al. WDR3 gene haplotype is associated with thyroid cancer risk in a Spanish population. Thyroid 2010; 20: 803-9.
16. Arnaud-Lopez L, Usala G, Ceresini G, et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 2008; 82: 1270-80.
17. Baida A, Akdi M, Gonzalez-Flores E, et al. Strong association of chromosome 1p12 loci with thyroid cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2008; 17: 1499-504.
18. Best T, Li D, Skol AD, et al. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med 2011; 17: 941-3.
19. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 2009; 41: 460-4.
20. He H, Nagy R, Liyanarachchi S, et al. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 2009; 69: 625-31.
21. Jazdzewski K, Murray EL, Franssila K, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269-74.
22. Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005; 97: 724-32.
23. Drozdovitch V, Khrouch V, Maceika E, et al. Reconstruction of radiation doses in a case-control study of thyroid cancer following the Chernobyl accident. Health Phys 2010; 99: 1-16.
24. WHO. Health effects of the Chernobyl accident: an overview. In: UN Chernobyl Forum. Geneva: WHO, 2006. Available at: http://www.who.int/ionizing- radiation/chernobyl/backgrounder/en/. Last accessed date April 2006.
25. Korobova E, Anoshko Y, Kesminiene A, et al. Evaluation of stable iodine status of the areas affected by the Chernobyl accident in an epidemiological study in Belarus and the Russian Federation. J G Explo 2010; 107: 124-35.
26. Grimberg J, Nawoschik S, Belluscio L, et al. A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res 1989; 17: 8390.
27. Landa I, Ruiz-Llorente S, Montero-Conde C, et al. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 2009; 5: e1000637.
28. Bau DT, Chang CH, Tsai MH, et al. Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility. Laryngoscope 2010; 120: 2417-22.
29. Lee SA, Lee KM, Lee SJ, et al. Antioxidant vitamins intake, ataxia telangiectasia mutated (ATM) genetic polymorphisms, and breast cancer risk. Nutr Cancer 2010; 62: 1087-94.
30. Lo YL, Hsiao CF, Jou YS, et al. ATM polymorphisms and risk of lung cancer among never smokers. Lung Cancer 2010; 69: 148-54.
31. Malmer BS, Feychting M, Lonn S, et al. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol 2007; 82: 229-37.
32. Nguyen-Dumont T, Calvez-Kelm FL, Forey N, et al. Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis. Hum Mutat 2009; 30: 884-90.
33. Drozdovitch V, Maceika E, Khrouch V, et al. Uncertainties in individual doses in a case-control study of thyroid cancer after the Chernobyl accident. Radiat Protect Dosimetry 2007; 127: 540-3.
34. Carre A, Castanet M, Sura-Trueba S, et al. Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum Genet 2007; 122: 467-76.
35. Macchia PE, Mattei MG, Lapi P, et al. Cloning, chromosomal localization and identification of polymorphisms in the human thyroid transcription factor 2 gene (TITF2). Biochimie 1999; 81: 433-40.
36. Reiners C, Demidchik YE,. Differentiated thyroid cancer in childhood: pathology, diagnosis, therapy. Pediatr Endocrinol Rev 2003; 1 (Suppl 2): 230-5; discussion 5-6.
37. Angele S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003; 63: 8717-25.
38. Alsbeih G, El-Sebaie M, Al-Harbi N, et al. Radiosensitivity of human fibroblasts is associated with amino acid substitution variants in susceptible genes and correlates with the number of risk alleles. Int J Radiat Oncol Biol Phys 2007; 68: 229-35.
39. Edvardsen H, Tefre T, Jansen L, et al. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. Radiat Oncol 2007; 2: 25.
40. Arden KC,. FoxO: linking new signaling pathways. Mol Cell 2004; 14: 416-18.
41. Amiel J, Trochet D, Clement-Ziza M, et al. Polyalanine expansions in human. Hum Mol Genet 2004; 13 (Spec No 2): R235-R243.
42. Licht JD, Hanna-Rose W, Reddy JC, et al. Mapping and mutagenesis of the amino-terminal transcriptional repression domain of the Drosophila Kruppel protein. Mol Cell Biol 1994; 14: 4057-66.
43. Szczepanek E, Ruchala M, Szaflarski W, et al. FOXE1 polyalanine tract length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid. Horm Res Paediatr 2011; 75: 329-34.
44. Bullock M, Duncan EL, O'Neill C, et al. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab 2012; 97: E1814-E1819.
45. Venza I, Visalli M, Parrillo L, et al. MSX1 and TGF-beta3 are novel target genes functionally regulated by FOXE1. Hum Mol Genet 2011; 20: 1016-25.
46. Kallel R, Belguith-Maalej S, Akdi A, et al. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma. Cancer Biomark 2010; 8: 43-51.
47. Tomaz RA, Sousa I, Silva JG, et al. Clin Endocrinol. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin Endocrinol 2012; 77: 926-33.
48. Fagman H, Nilsson M,. Morphogenetics of early thyroid development. J Mol Endocrinol 2011; 46: R33-R42.
49. Jendrzejewski J, He H, Radomska HS, et al. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci USA 2012; 109: 8646-51.
50. Leeman-Neill RJ, Brenner AV, Little MP, et al. RET/PTC and PAX8/PPARgamma chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer 2013; 119: 1792-9.